Sumitomo Pharma Co Ltd (STU:DPM)
€ 3.5 0.02 (0.57%) Market Cap: 1.41 Bil Enterprise Value: 3.06 Bil PE Ratio: 0 PB Ratio: 2.04 GF Score: 63/100

Sumitomo Dainippon Pharma Co Ltd Frontier Business Briefing Session Transcript

Sep 08, 2021 / NTS GMT
Release Date Price: €15.8 (+1.28%)
Unidentified Company Representative

Thank you very much for taking time out of your busy schedule to join us today for th Sumitomo Dainippon Pharma, Frontier business meeting, FBO Showcase. FBO is the abbreviation for Frontier Business Office.

We would like to introduce the vision, portfolio and major projects of frontier business. Today's presentation material was e-mailed to you and is also available on our website. You can also see it on the screen. However, the slides for each part are not numbered sequentially. So please note that the page numbers are different from those in your handouts. There will be time for questions after the presentations. Please note that this meeting will be recorded for later distribution on the website.

I would now like to introduce today's attendees. From left to right, the first row of the screen, President and CEO, Hiroshi Nomura, Executive Vice President and Chief Scientific Officer, Toru Kimura. Senior Executive Officer in charge of Frontier business, Hiroyuki Baba. Second row from left, Senior Director, Frontier Business Office, Takehiko Nomura. Officers,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot